medication
-
Technology
TGA doubles down on rejection of Alzheimer’s drug
The Australian Therapeutic Goods Administration (TGA) has confirmed its decision not to register Alzheimer's disease drug lecanemab (LEQEMBI). Lecanemab is…
Read More » -
In the best interest of the child
New research shows that women who breastfeed are not receiving adequate advice as to the possible effects of medication. Research…
Read More »